2m 2m 2m 2m 2m 2m 2m
CUE BIOPHARMA (CUE)
NASDAQ
$26.50-$2.12 (-7.42%)
Price as of Jun 03, 2026 7:04 PM EDT- $74.9MMarket Cap
- 51.02%1-Year Change
- BiotechnologyIndustry
CUE BIOPHARMA (CUE)
$26.50-$2.12 (-7.42%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
BLEICHROEDER LP | 259.49% | 6.8M | 0 (0.00%) | Mar 31, 2026 |
CATALYTIC WEALTH RIA, LLC | 176.25% | 4.6M | 0 (0.00%) | Mar 31, 2026 |
VANGUARD GROUP INC | 114.69% | 3.0M | -25,288 (-0.84%) | Dec 31, 2025 |
N/A | 93.51% | 2.5M | +2.5M (+100.00%) | Mar 31, 2026 |
LION POINT CAPITAL, LP | 83.82% | 2.2M | 0 (0.00%) | Mar 31, 2026 |
GEODE CAPITAL MANAGEMENT, LLC | 40.51% | 1.1M | +261,399 (+24.55%) | Mar 31, 2026 |
BLACKROCK INC. | 28.80% | 756,736 | -1.5M (-196.55%) | Jun 30, 2024 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
SPDR SERIES TRUST | 38.50% | 1.0M | 0 (0.00%) | Jan 31, 2026 |
Federated Hermes MDT Series | 11.94% | 313,700 | 0 (0.00%) | Jan 31, 2026 |
VANGUARD SCOTTSDALE FUNDS | 6.51% | 171,145 | 0 (0.00%) | Feb 28, 2026 |
TIAA-CREF FUNDS | 5.57% | 146,326 | 0 (0.00%) | Jan 31, 2026 |
SCHWAB STRATEGIC TRUST | 4.75% | 124,900 | 0 (0.00%) | Feb 28, 2026 |
Direxion Shares ETF Trust | 4.36% | 114,585 | 0 (0.00%) | Jan 31, 2026 |
iSHARES TRUST | 4.19% | 110,050 | 0 (0.00%) | Feb 28, 2026 |
Current Ownership Distribution
- Institutions282.4M (80.22%)
- Mutual Funds64.7M (18.39%)
- Insiders4.9M (1.39%)
- Other0 (0.00%)
Insider Transactions
- 1.39% (4.9M)Current InsiderOwnership (%, shares)
- 2Number of InsiderBuying (last 12 months)
- $153,841.43Amount of InsiderBuying (last 12 months)
- 0Number of InsiderSelling (last 12 months)
- $0.00Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Lin Shao-Lee Chief Executive Officer | Buy | Jun 01, 2026 | $999,966.00 | 90,906 | $11.00 | 90,906 |
Lin Shao-Lee Chief Executive Officer | Buy | Jun 01, 2026 | $0.00 | 45,453 | $0.00 | 45,453 |
Meehan Viola Mong | Award | May 30, 2026 | $0.00 | 1,626 | $0.00 | 1,626 |
Lin Shao-Lee CHIEF EXECUTIVE OFFICER | Award | May 03, 2026 | $0.00 | 655,074 | $0.00 | 655,074 |
Lin Shao-Lee CHIEF EXECUTIVE OFFICER | Award | May 03, 2026 | $0.00 | 327,537 | $0.00 | 327,537 |
Sandercock Colin SVP, GENERAL COUNSEL | Award | Apr 09, 2026 | $0.00 | 200,000 | $0.00 | 200,000 |
Baker Daniel G. CHIEF DEVELOPMENT OFFICER | Award | Apr 09, 2026 | $0.00 | 100,000 | $0.00 | 100,000 |
Warren Lucinda CHIEF BUSINESS OFFICER | Award | Apr 09, 2026 | $0.00 | 250,000 | $0.00 | 250,000 |
Morich Frank | Award | Jan 02, 2026 | $0.00 | 24,400 | $0.00 | 24,400 |
Sarraf Pasha | Award | Jan 02, 2026 | $0.00 | 24,400 | $0.00 | 24,400 |
Verheyen Patrick | Award | Jan 02, 2026 | $0.00 | 24,400 | $0.00 | 24,400 |
Broadfoot Jill Marie | Award | Jan 02, 2026 | $0.00 | 24,400 | $0.00 | 24,400 |
Garzone Pamela | Award | Jan 02, 2026 | $0.00 | 24,400 | $0.00 | 24,400 |
Sarraf Pasha | Buy | Dec 30, 2025 | $1,308.45 | 4,229 | $0.31 | 4,229 |
Sarraf Pasha | Buy | Dec 30, 2025 | $23,167.54 | 77,148 | $0.30 | 81,377 |
Sarraf Pasha | Buy | Dec 30, 2025 | $27,596.98 | 86,947 | $0.32 | 168,324 |
Sarraf Pasha | Buy | Dec 30, 2025 | $24,325.32 | 78,116 | $0.31 | 246,440 |
Sarraf Pasha | Buy | Dec 30, 2025 | $23,348.97 | 77,417 | $0.30 | 323,857 |
Baker Daniel G. CHIEF DEVELOPMENT OFFICER | Award | Sep 29, 2025 | $0.00 | 50,000 | $0.00 | 50,000 |
Warren Lucinda CHIEF BUSINESS OFFICER | Award | Sep 29, 2025 | $0.00 | 125,000 | $0.00 | 125,000 |
Azam Usman CHIEF EXECUTIVE OFFICER | Award | Sep 29, 2025 | $0.00 | 1.9M | $0.00 | 1.9M |
Broadfoot Jill Marie | Award | Jun 04, 2025 | $0.00 | 48,800 | $0.00 | 48,800 |
Baker Daniel G. CHIEF DEVELOPMENT OFFICER | Award | Mar 21, 2025 | $0.00 | 100,000 | $0.00 | 100,000 |
Millar Kerri-Ann CHIEF FINANCIAL OFFICER | Award | Mar 21, 2025 | $0.00 | 200,000 | $0.00 | 200,000 |
Warren Lucinda CHIEF BUSINESS OFFICER | Award | Mar 21, 2025 | $0.00 | 250,000 | $0.00 | 250,000 |
Levisetti Matteo Chief Medical Officer | Award | Mar 21, 2025 | $0.00 | 250,000 | $0.00 | 250,000 |
Sandercock Colin SVP, GENERAL COUNSEL | Award | Mar 21, 2025 | $0.00 | 200,000 | $0.00 | 200,000 |
PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | Award | Mar 21, 2025 | $0.00 | 450,000 | $0.00 | 450,000 |
Sarraf Pasha | Award | Mar 10, 2025 | $0.00 | 48,800 | $0.00 | 48,800 |
Garzone Pamela | Award | Jan 02, 2025 | $0.00 | 24,400 | $0.00 | 24,400 |